Cholesterol-Lowering Therapy (eBook, PDF)
Evaluation of Clinical Trial Evidence
Redaktion: Grundy, Scott M.
63,95 €
63,95 €
inkl. MwSt.
Sofort per Download lieferbar
32 °P sammeln
63,95 €
Als Download kaufen
63,95 €
inkl. MwSt.
Sofort per Download lieferbar
32 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
63,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
32 °P sammeln
Cholesterol-Lowering Therapy (eBook, PDF)
Evaluation of Clinical Trial Evidence
Redaktion: Grundy, Scott M.
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Reveals important new results from clinical trials conducted in Scandinavia, Scotland, Australia, Canada, and the United States. This timely reference reviews the vast body of clinical trial evidence supporting the once controversial view that high levels of serum cholesterol are a major risk factor in coronary heart disease (CHD). The studies p
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
- Größe: 142.82MB
Andere Kunden interessierten sich auch für
Nutraceutical Delivery Systems (eBook, PDF)145,95 €
Linda H. ChenNutritional Aspects Of Aging (eBook, PDF)52,95 €
Internet Guide to Anti-Aging and Longevity (eBook, PDF)47,95 €
Sheldon ReiserMetabolic Effects Of Dietary Fructose (eBook, PDF)52,95 €
Alan B. ClemetsonVitamin C (eBook, PDF)216,95 €
Bandaru S. ReddyDiet, Nutrition and Cancer: A Critical Evaluation (eBook, PDF)52,95 €
Arnis KuksisFat Absorption (eBook, PDF)52,95 €-
-
-
Reveals important new results from clinical trials conducted in Scandinavia, Scotland, Australia, Canada, and the United States. This timely reference reviews the vast body of clinical trial evidence supporting the once controversial view that high levels of serum cholesterol are a major risk factor in coronary heart disease (CHD). The studies p
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis eBooks
- Seitenzahl: 352
- Erscheinungstermin: 5. November 1999
- Englisch
- ISBN-13: 9781420001396
- Artikelnr.: 54253550
- Verlag: Taylor & Francis eBooks
- Seitenzahl: 352
- Erscheinungstermin: 5. November 1999
- Englisch
- ISBN-13: 9781420001396
- Artikelnr.: 54253550
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Scott M. Grundy
Cholesterol-Lowering Clinical Trials: A Historical Perspective Scott M.
Grundy Scandinavian Simvastatin Survival Study (4S) Terje R. Pedersen The
Cholesterol and Recurrent Events Trial (CARE): The Effect of Pravastatin on
Coronary Events After Myocardial Infarction in Patients with Average
Cholesterol Levels Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé, C.
Morton Hawkins, Barry R. Davis, Jean L. Rouleau, Thomas G. Cole, and Eugene
Braunwald Lessons from the West of Scotland Coronary Prevention Study
(WOSCOPS) James Shepherd and Allan Gaw Program on the Surgical Control of
the Hyperlipidemias (POSCH) Trial: A Pivotal 25-Year Study Henry Buchwald
The Air Force/Texas Atherosclerosis Prevention Study (AFCAPS/TexCAPS):
Primary Prevention of Acute Major Coronary Events in Women and Men with
Average Cholesterol Stephen Weis, Michael Clearfield, Lt. Col. John R.
Downs, and Antonio M. Gotto, Jr. Long-Term Intervention with Pravastatin in
Ischemic Disease (LIPID) Study: Clinical Implications for Cardiovascular
Practice Andrew M. Tonkin and David Hunt Angiographic Results of
Lipid-Lowering Trials: A Systematic Review and Meta-Analysis Cheryl L.
Holmes, Michael Schulzer, and G. B. John Mancini Biochemical Correlates of
Plaque Progression and Coronary Events Melissa Ferraro-Borgida and David
Waters Lipid Therapy to Stabilize the Vulnerable Atherosclerotic Plaque:
New Insights into the Prevention of Cardiovascular Events B. Greg Brown and
Xue-Qiao Zhao Cholesterol-Lowering Trials with Carotid Ultrasonographic
Outcomes Robert P. Byington Cholesterol Lowering Reduces Mortality: The
Statins David J. Gordon
Grundy Scandinavian Simvastatin Survival Study (4S) Terje R. Pedersen The
Cholesterol and Recurrent Events Trial (CARE): The Effect of Pravastatin on
Coronary Events After Myocardial Infarction in Patients with Average
Cholesterol Levels Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé, C.
Morton Hawkins, Barry R. Davis, Jean L. Rouleau, Thomas G. Cole, and Eugene
Braunwald Lessons from the West of Scotland Coronary Prevention Study
(WOSCOPS) James Shepherd and Allan Gaw Program on the Surgical Control of
the Hyperlipidemias (POSCH) Trial: A Pivotal 25-Year Study Henry Buchwald
The Air Force/Texas Atherosclerosis Prevention Study (AFCAPS/TexCAPS):
Primary Prevention of Acute Major Coronary Events in Women and Men with
Average Cholesterol Stephen Weis, Michael Clearfield, Lt. Col. John R.
Downs, and Antonio M. Gotto, Jr. Long-Term Intervention with Pravastatin in
Ischemic Disease (LIPID) Study: Clinical Implications for Cardiovascular
Practice Andrew M. Tonkin and David Hunt Angiographic Results of
Lipid-Lowering Trials: A Systematic Review and Meta-Analysis Cheryl L.
Holmes, Michael Schulzer, and G. B. John Mancini Biochemical Correlates of
Plaque Progression and Coronary Events Melissa Ferraro-Borgida and David
Waters Lipid Therapy to Stabilize the Vulnerable Atherosclerotic Plaque:
New Insights into the Prevention of Cardiovascular Events B. Greg Brown and
Xue-Qiao Zhao Cholesterol-Lowering Trials with Carotid Ultrasonographic
Outcomes Robert P. Byington Cholesterol Lowering Reduces Mortality: The
Statins David J. Gordon
Cholesterol-Lowering Clinical Trials: A Historical Perspective Scott M.
Grundy Scandinavian Simvastatin Survival Study (4S) Terje R. Pedersen The
Cholesterol and Recurrent Events Trial (CARE): The Effect of Pravastatin on
Coronary Events After Myocardial Infarction in Patients with Average
Cholesterol Levels Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé, C.
Morton Hawkins, Barry R. Davis, Jean L. Rouleau, Thomas G. Cole, and Eugene
Braunwald Lessons from the West of Scotland Coronary Prevention Study
(WOSCOPS) James Shepherd and Allan Gaw Program on the Surgical Control of
the Hyperlipidemias (POSCH) Trial: A Pivotal 25-Year Study Henry Buchwald
The Air Force/Texas Atherosclerosis Prevention Study (AFCAPS/TexCAPS):
Primary Prevention of Acute Major Coronary Events in Women and Men with
Average Cholesterol Stephen Weis, Michael Clearfield, Lt. Col. John R.
Downs, and Antonio M. Gotto, Jr. Long-Term Intervention with Pravastatin in
Ischemic Disease (LIPID) Study: Clinical Implications for Cardiovascular
Practice Andrew M. Tonkin and David Hunt Angiographic Results of
Lipid-Lowering Trials: A Systematic Review and Meta-Analysis Cheryl L.
Holmes, Michael Schulzer, and G. B. John Mancini Biochemical Correlates of
Plaque Progression and Coronary Events Melissa Ferraro-Borgida and David
Waters Lipid Therapy to Stabilize the Vulnerable Atherosclerotic Plaque:
New Insights into the Prevention of Cardiovascular Events B. Greg Brown and
Xue-Qiao Zhao Cholesterol-Lowering Trials with Carotid Ultrasonographic
Outcomes Robert P. Byington Cholesterol Lowering Reduces Mortality: The
Statins David J. Gordon
Grundy Scandinavian Simvastatin Survival Study (4S) Terje R. Pedersen The
Cholesterol and Recurrent Events Trial (CARE): The Effect of Pravastatin on
Coronary Events After Myocardial Infarction in Patients with Average
Cholesterol Levels Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé, C.
Morton Hawkins, Barry R. Davis, Jean L. Rouleau, Thomas G. Cole, and Eugene
Braunwald Lessons from the West of Scotland Coronary Prevention Study
(WOSCOPS) James Shepherd and Allan Gaw Program on the Surgical Control of
the Hyperlipidemias (POSCH) Trial: A Pivotal 25-Year Study Henry Buchwald
The Air Force/Texas Atherosclerosis Prevention Study (AFCAPS/TexCAPS):
Primary Prevention of Acute Major Coronary Events in Women and Men with
Average Cholesterol Stephen Weis, Michael Clearfield, Lt. Col. John R.
Downs, and Antonio M. Gotto, Jr. Long-Term Intervention with Pravastatin in
Ischemic Disease (LIPID) Study: Clinical Implications for Cardiovascular
Practice Andrew M. Tonkin and David Hunt Angiographic Results of
Lipid-Lowering Trials: A Systematic Review and Meta-Analysis Cheryl L.
Holmes, Michael Schulzer, and G. B. John Mancini Biochemical Correlates of
Plaque Progression and Coronary Events Melissa Ferraro-Borgida and David
Waters Lipid Therapy to Stabilize the Vulnerable Atherosclerotic Plaque:
New Insights into the Prevention of Cardiovascular Events B. Greg Brown and
Xue-Qiao Zhao Cholesterol-Lowering Trials with Carotid Ultrasonographic
Outcomes Robert P. Byington Cholesterol Lowering Reduces Mortality: The
Statins David J. Gordon







